- Home
- CELC vs FPH Comparison
CELC vs FPH Comparison
Compare CELC & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- FPH
- Stock Information
- Founded
- CELC 2011
- FPH 2009
- Country
- CELC United States
- FPH United States
- Employees
- CELC N/A
- FPH N/A
- Industry
- CELC Medical Specialities
- FPH Real Estate
- Sector
- CELC Health Care
- FPH Finance
- Exchange
- CELC Nasdaq
- FPH Nasdaq
- Market Cap
- CELC 327.3M
- FPH 340.3M
- IPO Year
- CELC 2017
- FPH 2017
- Fundamental
- Price
- CELC $10.53
- FPH $5.38
- Analyst Decision
- CELC Strong Buy
- FPH
- Analyst Count
- CELC 6
- FPH 0
- Target Price
- CELC $30.17
- FPH N/A
- AVG Volume (30 Days)
- CELC 195.9K
- FPH 181.9K
- Earning Date
- CELC 05-14-2025
- FPH 04-24-2025
- Dividend Yield
- CELC N/A
- FPH N/A
- EPS Growth
- CELC N/A
- FPH 69.50
- EPS
- CELC N/A
- FPH 1.24
- Revenue
- CELC N/A
- FPH $241,148,000.00
- Revenue This Year
- CELC N/A
- FPH N/A
- Revenue Next Year
- CELC N/A
- FPH N/A
- P/E Ratio
- CELC N/A
- FPH $4.39
- Revenue Growth
- CELC N/A
- FPH 11.66
- 52 Week Low
- CELC $7.58
- FPH $2.88
- 52 Week High
- CELC $19.77
- FPH $6.71
- Technical
- Relative Strength Index (RSI)
- CELC 51.41
- FPH 55.04
- Support Level
- CELC $9.64
- FPH $5.19
- Resistance Level
- CELC $11.66
- FPH $5.51
- Average True Range (ATR)
- CELC 0.66
- FPH 0.20
- MACD
- CELC -0.04
- FPH 0.04
- Stochastic Oscillator
- CELC 44.06
- FPH 55.77
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.